Love RC - Search Results

1

Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine.

Kelly DL, Conley RR, Love RC, Morrison JA, McMahon RP. Kelly DL, et al. Among authors: love rc. Ann Clin Psychiatry. 2008 Apr-Jun;20(2):71-8. doi: 10.1080/10401230802017050. Ann Clin Psychiatry. 2008. PMID: 18568578 Clinical Trial.

2

Novel versus conventional antipsychotic drugs.

Love RC. Love RC. Pharmacotherapy. 1996 Jan-Feb;16(1 Pt 2):6-10. Pharmacotherapy. 1996. PMID: 8778684 Review.

3

Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.

Conley RR, Tamminga CA, Bartko JJ, Richardson C, Peszke M, Lingle J, Hegerty J, Love R, Gounaris C, Zaremba S. Conley RR, et al. Am J Psychiatry. 1998 Jul;155(7):914-20. doi: 10.1176/ajp.155.7.914. Am J Psychiatry. 1998. PMID: 9659857 Clinical Trial.

4

Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months.

Kelly DL, Conley RR, Love RC, Horn DS, Ushchak CM. Kelly DL, et al. Among authors: love rc. J Child Adolesc Psychopharmacol. 1998;8(3):151-9. doi: 10.1089/cap.1998.8.151. J Child Adolesc Psychopharmacol. 1998. PMID: 9853689 Clinical Trial.

5

Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: comparison with risperidone.

Moore DB, Kelly DL, Sherr JD, Love RC, Conley RR. Moore DB, et al. Among authors: love rc. Am J Health Syst Pharm. 1998 Dec 15;55(24 Suppl 4):S17-9. doi: 10.1093/ajhp/55.suppl_4.S17. Am J Health Syst Pharm. 1998. PMID: 9872689 No abstract available.

6

Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.

Conley RR, Love RC, Kelly DL, Bartko JJ. Conley RR, et al. Among authors: love rc. Am J Psychiatry. 1999 Jun;156(6):863-8. doi: 10.1176/ajp.156.6.863. Am J Psychiatry. 1999. PMID: 10360124

7

A dose-outcome analysis of risperidone.

Love RC, Conley RR, Kelly DL, Bartko JJ. Love RC, et al. J Clin Psychiatry. 1999 Nov;60(11):771-5. doi: 10.4088/jcp.v60n1110. J Clin Psychiatry. 1999. PMID: 10584767

8

Pharmacology and clinical experience with risperidone.

Love RC, Nelson MW. Love RC, et al. Expert Opin Pharmacother. 2000 Dec;1(7):1441-53. doi: 10.1517/14656566.1.7.1441. Expert Opin Pharmacother. 2000. PMID: 11249477 Review.

9

Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine.

Kelly DL, Nelson MW, Love RC, Yu Y, Conley RR. Kelly DL, et al. Among authors: love rc. Psychiatr Serv. 2001 May;52(5):676-8. doi: 10.1176/appi.ps.52.5.676. Psychiatr Serv. 2001. PMID: 11331805

10

Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials.

McMahon RP, Kelly DL, Kreyenbuhl J, Kirkpatrick B, Love RC, Conley RR. McMahon RP, et al. Among authors: love rc. Neuropsychopharmacology. 2002 Apr;26(4):537-45. doi: 10.1016/S0893-133X(01)00387-6. Neuropsychopharmacology. 2002. PMID: 11927178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters